Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX).
- Disclosed ownership: 6.8%.
- Date of event: 31 Dec 2025.
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 6.8% ownership in TENAX THERAPEUTICS, INC. Common Stock, par value $0.0001 per share (TENX) on 31 Dec 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 6.8% | 423,415 | 0 | 423,415 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 6.8% | 423,415 | 0 | 423,415 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 6.8% | 423,415 | 0 | 423,415 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |